A comprehensive antigen production and characterization study for easy-to-implement, highly specific and quantitative SARS-CoV-2 antibody assays
Authors:
- Miriam KlausbergerMKMiriam Klausberger
- Mark DürkopMark Dürkop
- Helmuth HaslacherHHHelmuth Haslacher
- Gordana Wozniak-KnoppGWGordana Wozniak-Knopp
- Monika Cserjan-PuschmannMCMonika Cserjan-Puschmann
- Thomas PerkmannTPThomas Perkmann
- Nico LinggNico Lingg
- Patricia Pereira AguilarPatricia Pereira Aguilar
- Elisabeth LaurentELElisabeth Laurent
- Jelle De VosJVJelle De Vos
Preprint
Abstract
Antibody tests are essential tools to investigate humoral immunity following SARS-CoV-2 infection. While first-generation antibody tests have primarily provided qualitative results with low specificity, accurate seroprevalence studies and tracking of antibody levels over time require highly specific, sensitive and quantitative test setups. Here, we describe two quantitative ELISA antibody tests based on the SARS-CoV-2 spike receptor-binding domain and the nucleocapsid protein. Comparative expression in bacterial, insect, mammalian and plant-based platforms enabled the identification of new antigen designs with superior quality and high suitability as diagnostic reagents. Both tests scored excellently in clinical validations with multi-centric specificity and sensitivity cohorts and showed unprecedented correlation with SARS-CoV-2 neutralization titers. Orthogonal testing increased assay specificity to 99.8%, thereby enabling robust serodiagnosis in low-prevalence settings. The inclusion of a calibrator permits accurate quantitative monitoring of antibody concentrations in samples collected at different time points during the acute and convalescent phase of COVID-19.Keywords
All Related Versions
- Published version: EBioMedicine, 67, 103348.
This publication has 60 references indexed in Scilit:
- Dual ELISA using SARS-CoV-2 nucleocapsid protein produced in E. coli and CHO cells reveals epitope masking by N-glycosylationBiochemical and Biophysical Research Communications, 2021
- Production of Circularly Permuted Caspase-2 for Affinity Fusion-Tag Removal: Cloning, Expression in Escherichia coli, Purification, and CharacterizationBiomolecules, 2020
- Increasing test specificity without impairing sensitivity - lessons learned from SARS-CoV-2 serologymedRxiv, 2020
- Rapid production of SARS-CoV-2 receptor binding domain (RBD) and spike specific monoclonal antibody CR3022 in Nicotiana benthamianaScientific Reports, 2020
- N‐terminally truncated nucleocapsid protein of SARS‐CoV‐2 as a better serological marker than whole nucleocapsid protein in evaluating the immunogenicity of inactivated SARS‐CoV‐2Journal of Medical Virology, 2020
- Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysisBMJ, 2020
- Connecting clusters of COVID-19: an epidemiological and serological investigationThe Lancet Infectious Diseases, 2020
- Antibody responses to SARS-CoV-2 in patients with COVID-19Nature Medicine, 2020
- Bacteriophage Inspired Growth-Decoupled Recombinant Protein Production in Escherichia coliACS Synthetic Biology, 2020
- Expression of SARS-coronavirus nucleocapsid protein in Escherichia coli and Lactococcus lactis for serodiagnosis and mucosal vaccinationApplied Microbiology and Biotechnology, 2005